However, clinical results from the application of TLR4 inhibitors, including TAK-242 and eritoran tetrasodium (E5564), failed to show either the inhibition of inflammatory responses or a decrease in the mortality rate in sepsis patients (64, 65). This evidence concerns the gene TLR4 and Sepsis.